Literature DB >> 11289146

K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1.

H Sheng1, J Shao, R N Dubois.   

Abstract

Cyclooxygenase (COX) 2 expression is regulated via the Ras signaling pathway, and induction of mutated Ras rapidly increases COX-2 levels in intestinal epithelial cells. Protein kinase B (Akt/PKB) is an important effector of Ras signaling and a critical component of Ras-mediated transformation. Here we investigate the role of Akt/PKB in K-Ras-mediated induction of COX-2. Rat intestinal epithelial cells (IEC-6) were transfected with an inducible K-RasVal12 cDNA (IEC-iK-Ras cells). Addition of 5 mM isopropyl-1-thio-beta-D-galactopyranoside induced the expression of K-RasVal12, followed by increased activity of extracellular signal-regulated kinase and Akt/PKB. COX-2 levels were dramatically increased after induction of K-RasVal12. Inhibition of MAPK/ERK kinase activity by PD 98059 completely blocked the K-Ras-mediated induction of COX-2, whereas inhibition of PI3K/Akt/PKB activity with LY 294002 or by expressing a dominant negative Akt (Akt-K179M) partially blocked the induction of COX-2 by K-Ras. Transient transfection of cells with phosphatidylinositol 3-kinase and Akt expression vectors revealed that PI3/Akt/PKB activity predominantly regulates the stability of COX-2 mRNA. Thus, Akt/PKB activity is involved in K-Ras-induced expression of COX-2 and stabilization of COX-2 mRNA largely depends on the activation of Akt/PKB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289146

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

Review 1.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

2.  Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Authors:  Marianne Gervais; Céline Dugourd; Laurent Muller; Corinne Ardidie; Brigitte Canton; Laetitia Loviconi; Pierre Corvol; Hervé Chneiweiss; Catherine Monnot
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

Review 3.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells.

Authors:  Jianguo Du; Bo Jiang; John Barnard
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

5.  Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules.

Authors:  Elda Grabocka; Dafna Bar-Sagi
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

6.  Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells.

Authors:  H Sheng; J Shao; C M Townsend; B M Evers
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1).

Authors:  Gareth Sully; Jonathan L E Dean; Robin Wait; Lesley Rawlinson; Tomas Santalucia; Jeremy Saklatvala; Andrew R Clark
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

8.  Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.

Authors:  José M Escandell; Pawan Kaler; M Carmen Recio; Takehiko Sasazuki; Senji Shirasawa; Leonard Augenlicht; José-Luis Ríos; Lidija Klampfer
Journal:  Biochem Pharmacol       Date:  2008-05-08       Impact factor: 5.858

9.  Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2.

Authors:  Urszula Dougherty; Dario Cerasi; Ieva Taylor; Masha Kocherginsky; Ummuhan Tekin; Shamiram Badal; Lata Aluri; Amikar Sehdev; Sonia Cerda; Reba Mustafi; Jorge Delgado; Loren Joseph; Hongyan Zhu; John Hart; David Threadgill; Alessandro Fichera; Marc Bissonnette
Journal:  Clin Cancer Res       Date:  2009-11-10       Impact factor: 12.531

10.  Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Authors:  Sreelatha Gopinath; Sravan K Vanamala; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Cell Mol Life Sci       Date:  2009-09-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.